| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.52B | 26.88B | 25.24B | 29.27B | 27.25B | 23.00B |
| Gross Profit | 3.33B | 3.14B | 2.65B | 4.10B | 4.46B | 3.82B |
| EBITDA | 2.94B | 2.78B | 2.11B | 3.41B | 3.76B | 3.05B |
| Net Income | 663.53M | 447.93M | 121.28M | 1.27B | 1.55B | 1.49B |
Balance Sheet | ||||||
| Total Assets | 32.41B | 32.83B | 32.37B | 34.04B | 30.17B | 25.58B |
| Cash, Cash Equivalents and Short-Term Investments | 4.24B | 4.45B | 5.03B | 4.04B | 4.37B | 3.32B |
| Total Debt | 4.40B | 4.96B | 3.44B | 3.47B | 2.25B | 1.34B |
| Total Liabilities | 11.18B | 10.93B | 11.39B | 13.44B | 11.55B | 8.84B |
| Stockholders Equity | 21.22B | 21.90B | 20.98B | 20.59B | 18.63B | 16.74B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -904.97M | 1.08B | -1.10B | 280.27M | -11.64M |
| Operating Cash Flow | 0.00 | 732.03M | 3.10B | 1.81B | 3.33B | 2.51B |
| Investing Cash Flow | 0.00 | -1.65B | -1.76B | -3.00B | -2.97B | -2.40B |
| Financing Cash Flow | 0.00 | -98.63M | -511.55M | 535.79M | 386.59M | -113.92M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥27.43B | 13.32 | ― | 2.89% | 6.15% | 2.98% | |
73 Outperform | ¥19.30B | 18.81 | ― | 2.93% | -1.58% | 12.24% | |
72 Outperform | ¥23.12B | 7.24 | ― | 2.84% | 8.78% | 16.25% | |
66 Neutral | ¥19.32B | 9.82 | ― | 2.92% | 9.64% | 163.46% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥19.54B | 10.83 | 1.29% | 4.91% | -1.71% | ― | |
46 Neutral | ¥4.52B | -3.85 | ― | ― | -6.31% | -64.22% |